Recursion Pharmaceuticals, Inc. (RXRX:NASDAQ) closed at $3.70 on October 23, 2026, up 3.35% on the day. The stock trades 43.1% below its 52-week high of $6.50 and 33.6% above its 52-week low of $2.77. Over the past year, it lost 38.7%. Recursion Pharmaceuticals, Inc. is part of the Health Care sector.
In 252 trading sessions since October 23, 2025, RXRX closed higher on 105 days (42%). Its best day was October 5, 2026 (+16.02%) and its worst was October 16, 2026 (-16.71%). The stock moved 10% or more in a single session 9 times. It opened at least 5% above the previous day's high 4 times.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
Find more stocks like RXRX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.